PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 4, 2011Journal of Clinical Oncology216 citationsOpen Access

Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study

View Full Paper
ASAnthony J. SwerdlowCHCraig HigginsPSPaul Smith

Key Points

Key points are not available for this paper at this time.

Abstract

Although chemotherapy alone leads to raised risk of second malignancy, this risk is lower and affects fewer anatomic sites than that after combined modalities, and it is slight if at all after 15 years follow-up. The mechanism of lung cancer etiology may differ between chemotherapy and radiotherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Swerdlow et al. (2011) studied this question.

synapsesocial.com/papers/69dff6c8af3798be7f860404https://doi.org/10.1200/jco.2011.34.8268
Ask AI
Helpful
Bookmark
Share
View Full Paper